Health Canada approved Pediapharm Inc.'s Otixal for the treatment of acute otitis media with tympanostomy tubes in pediatric patients.
Otixal is an antibiotic and steroid combination ear drop.
Discover more about S&P Global’s offerings
Health Canada approves Pediapharm ear infection drug
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Commercial Banking Newsletter June Edition - 2022
Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push
Health Canada approved Pediapharm Inc.'s Otixal for the treatment of acute otitis media with tympanostomy tubes in pediatric patients.
Otixal is an antibiotic and steroid combination ear drop.